Announcing the Three TopShock TCT 2023 Finalists



The results are in. Our expert panel has spoken. Please join us in congratulating the finalists for TopShock 2023!


After weeks of deliberation and many cases reviewed, our judges have chosen the three best Coronary IVL cases to be presented at the Shockwave symposium on October 25, 11:00 AM - 12:00 PM at TCT in San Francisco. Congratulations to Drs. Sameh Sayfo, Kalaivani Mahadevan, and Tim O'Connor for your selection as the three finalists for TopShock 2023!


Dr. Sameh Sayfo, Texas, United States treated a complex calcified nodule in the proximal RCA at the take off of an anomalous Cx.




Dr. Kalaivani Mahadevan, United Kingdom treated a calcified nodule during high-risk PCI in STEMI.




Dr. Tim O'Connor, Ireland treated a heavily calcified, balloon uncrossable RCA displaying nodular, eccentric, and concentric calcium.





What's Next?


On October 25, 2023, Drs. O'Connor, Sayfo, and Mahadevan will present their full cases at the "TopShock: Vote for the Best Coronary IVL Case of 2023" symposium at TCT. Drs. Ziad Ali and James Spratt will moderate the symposium and the audience will vote live at TCT to select which of these great cases has earned the title of the TopShock of 2023. Make sure your voice is heard. Join us at TCT!

        •                                                       03_btnCal

      • Thank you to all of you around the world who participated. We look forward to seeing you in San Francisco!
    • Instagram_logo_2016.svg


      To see outstanding Shockwave IVL cases, follow @ShockwaveMedical on Instagram!




      To keep up on the real-time Shockwave IVL activities, follow @ShockwaveIVL on Twitter




Coronary Important Safety Information:


In the United States: Rx only 


Indications for Use— The Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave C2 and C2+ Coronary IVL Catheter is indicated for lithotripsy-enabled, low-pressure balloon dilatation of severely calcified, stenotic de novo coronary arteries prior to stenting.


Contraindications— The Shockwave C2 and C2+ Coronary IVL System is contraindicated for the following: This device is not intended for stent delivery. This device is not intended for use in carotid or cerebrovascular arteries.


Warnings—Use the IVL Generator in accordance with recommended settings as stated in the Operator’s Manual. The risk of a dissection or perforation is increased in severely calcified lesions undergoing percutaneous treatment, including IVL. Appropriate provisional interventions should be readily available. Balloon loss of pressure was associated with a numerical increase in dissection which was not statistically significant and was not associated with MACE. Analysis indicates calcium length is a predictor of dissection and balloon loss of pressure. IVL generates mechanical pulses which may cause atrial or ventricular capture in bradycardic patients. In patients with implantable pacemakers and defibrillators, the asynchronous capture may interact with the sensing capabilities. Monitoring of the electrocardiographic rhythm and continuous arterial pressure during IVL treatment is required. In the event of clinically significant hemodynamic effects, temporarily cease delivery of IVL therapy.


Precautions— Only to be used by physicians trained in angiography and intravascular coronary procedures. Use only the recommended balloon inflation medium. Hydrophilic coating to be wet only with normal saline or water and care must be taken with sharp objects to avoid damage to the hydrophilic coating. Appropriate anticoagulant therapy should be administered by the physician. Precaution should be taken when treating patients with previous stenting within 5mm of target lesion.


Potential adverse effects consistent with standard based cardiac interventions include– Abrupt vessel closure – Allergic reaction to contrast medium, anticoagulant and/or antithrombotic therapy-Aneurysm-Arrhythmia-Arteriovenous fistula-Bleeding complications-Cardiac tamponade or pericardial effusion-Cardiopulmonary arrest-Cerebrovascular accident (CVA)-Coronary artery/vessel occlusion, perforation, rupture or dissection-Coronary artery spasm-Death-Emboli (air, tissue, thrombus or atherosclerotic emboli)-Emergency or nonemergency coronary artery bypass surgery-Emergency or nonemergency percutaneous coronary intervention-Entry site complications-Fracture of the guide wire or failure/malfunction of any component of the device that may or may not lead to device embolism, dissection, serious injury or surgical intervention-Hematoma at the vascular access site(s)- Hemorrhage-Hypertension/Hypotension-Infection/sepsis/fever-Myocardial Infarction-Myocardial Ischemia or unstable angina-Pain-Peripheral Ischemia-Pseudoaneurysm-Renal failure/insufficiency-Restenosis of the treated coronary artery leading to revascularization-Shock/pulmonary edema-Slow flow, no reflow, or abrupt closure of coronary artery-Stroke Thrombus-Vessel closure, abrupt-Vessel injury requiring surgical repair-Vessel dissection, perforation, rupture, or spasm.


Risks identified as related to the device and its use: Allergic/immunologic reaction to the catheter material(s) or coating-Device malfunction, failure, or balloon loss of pressure leading to device embolism, dissection, serious injury or surgical intervention-Atrial or ventricular extrasystole-Atrial or ventricular capture.


Prior to use, please reference the Instructions for Use for more information on warnings, precautions and adverse


Please contact your local Shockwave representative for specific country availability and refer to the Shockwave C2 instructions for use containing important safety information.


false false Announcing the Top Three TopShock TCT 2023 Finalists Click Here to View

To keep you apprised of the latest IVL news, education, and cases, please share your selected interests.